Asclemed USA Inc. dba Enovachem Pharmaceuticals: Drug Recall

Recall #D-0330-2021 · 03/19/2021

Class III: Low Risk

Recall Details

Recall Number
D-0330-2021
Classification
Class III
Product Type
Drug
Recalling Firm
Asclemed USA Inc. dba Enovachem Pharmaceuticals
Status
Ongoing
Date Initiated
03/19/2021
Location
Torrance, CA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Reason for Recall

Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.

Product Description

Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608

Distribution Pattern

Distributed to three physicians in the following states: CA, LA (Enovachem). DocRx distributed recalled product to one Distributor located in AL.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.